AMGEVITA 40 mg solution for injection in pre-filled pen

DRUG3 trials

Sponsors

Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University Hospital, Universitetssykehuset Nord-Norge HF, Sint Maartenskliniek Stichting

Conditions

Rheumatoid arthritisUlcerative colitis

Phase 2

Debut of Ulcerative Colitis: selective Top-down strategy - the DUCT trial

Not yet recruitingCTIS2024-519891-17-00

Universitetssykehuset Nord-Norge HFUlcerative colitis

Target: 200Updated: 2025-06-19

Phase 4

A multi-center, open, randomized, 18-month, parallel-group, superiority study to compare the effect of proactive therapeutic drug monitoring versus standard of care with regards to maintenance of sustained disease control without flare in adults with rheumatoid arthritis treated with a subcutaneous tumor necrosis factor inhibitor

RecruitingCTIS2023-510184-35-00

Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University HospitalRheumatoid arthritis

Start: 2024-08-20Target: 410Updated: 2025-09-12

DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial

Not yet recruitingCTIS2026-525316-33-00

Sint Maartenskliniek StichtingRheumatoid arthritis

Target: 202Updated: 2026-06-09